Background
Methods
Study Subjects
Statistical Methods
Results
Ages 0–14 | Ages 15–24 | ||||
---|---|---|---|---|---|
No. | Rate (95% CI) | No. | Rate (95% CI) | ||
CNS tumours
| M | 382 | 31.7 (28.5,35.0) | 224 | 27.3 (23.7,30.9) |
F | 309 | 27.6 (24.4,30.7) | 165 | 20.2 (17.1,23.3) | |
Ependymomas | M | 51 | 4.6 (3.3,5.8) | 21 | 2.6 (1.6,3.9) |
F | 21 | 2.0 (1.2,3.1) | 6 | 0.8 (0.3,1.6) | |
Astrocytomas | M | 137 | 11.1 (9.2,12.9) | 76 | 9.3 (7.2,11.4) |
F | 126 | 11.2 (9.2,13.1) | 54 | 6.6 (4.8,8.4) | |
PNET | M | 78 | 6.7 (5.2,8.2) | 13 | 1.6 (0.8,2.7) |
F | 45 | 4.2 (3.0,5.4) | 7 | 0.9 (0.4,1.8) | |
Other gliomas | M | 34 | 2.9 (1.9,3.8) | 36 | 4.3 (2.9,5.8) |
F | 34 | 3.0 (2.0,4.0) | 26 | 3.2 (2.1,4.7) | |
Sympathetic nervous system tumours
| M | 102 | 9.8 (7.9,11.7) | 9 | 1.1 (0.5,2.1) |
F | 95 | 9.7 (7.8,11.7) | 9 | 1.1 (0.5,2.2) | |
Retinoblastoma
| M | 38 | 3.9 (2.6,5.1) | 0 | - |
F | 50 | 5.4 (3.9,6.8) | 0 | - | |
Renal tumours
| M | 71 | 6.8 (5.2,8.4) | 8 | 0.9 (0.4,1.8) |
F | 85 | 8.7 (6.9,10.6) | 7 | 0.8 (0.3,1.7) | |
Hepatoblastomas
| M | 7 | 0.7 (0.3,1.5) | 0 | - |
F | 10 | 1.0 (0.5,1.9) | 2 | 0.2 (0.0,0.8) | |
Bone tumours
| M | 65 | 4.7 (3.5,5.8) | 114 | 14.2 (11.6,16.8) |
F | 56 | 4.3 (3.2,5.5) | 66 | 8.3 (6.3,10.3) | |
Osteosarcoma | M | 34 | 2.4 (1.6,3.3) | 60 | 7.5 (5.6,9.5) |
F | 37 | 2.8 (1.9,3.8) | 39 | 4.9 (3.4,6.5) | |
Ewing's sarcoma | M | 29 | 2.1 (1.4,3.0) | 36 | 4.5 (3.0,5.9) |
F | 16 | 1.3 (0.7,2.1) | 16 | 2.0 (1.2,3.3) | |
Soft tissue sarcomas
| M | 127 | 11.0 (9.1,13.0) | 89 | 10.9 (8.6,13.2) |
F | 72 | 6.2 (4.8,7.7) | 94 | 11.7 (9.3,14.0) | |
Rhabdomyosarcoma | M | 75 | 6.8 (5.3,8.4) | 14 | 1.8 (1.0,3.0) |
F | 39 | 3.6 (2.5,4.7) | 21 | 2.7 (1.6,4.1) | |
Other | M | 52 | 4.2 (3.0,5.4) | 75 | 9.1 (7.1,11.2) |
F | 33 | 2.6 (1.7,3.5) | 73 | 9.0 (6.9,11.1) | |
Germ cell tumours
| M | 55 | 5.2 (3.8,6.6) | 292 | 34.8 (30.8,38.8) |
F | 60 | 5.5 (4.1,6.9) | 127 | 15.4 (12.7,18.1) | |
Gonadal | M | 32 | 3.2 (2.1,4.3) | 260 | 31.0 (27.2,34.7) |
F | 18 | 1.4 (0.8,2.2) | 86 | 10.4 (8.2,12.6) | |
Non-gonadal | M | 23 | 2.0 (1.3,3.0) | 32 | 3.8 (2.5,5.2) |
F | 42 | 4.1 (2.9,5.4) | 41 | 5.0 (3.5,6.6) | |
Carcinomas
| M | 39 | 2.9 (2.0,3.9) | 221 | 26.4 (22.9,29.9) |
F | 54 | 4.5 (3.3,5.7) | 472 | 56.5 (51.4,61.6) | |
Thyroid | M | 9 | 0.7 (0.3,1.3) | 23 | 2.8 (1.7,4.1) |
F | 9 | 0.7 (0.3,1.4) | 61 | 7.4 (5.6,9.3) | |
Melanoma | M | 7 | 0.5 (0.2,1.1) | 61 | 7.4 (5.5,9.2) |
F | 16 | 1.4 (0.8,2.3) | 148 | 17.9 (15.0,20.7) | |
Skin | M | 4 | 0.3 (0.1,0.7) | 39 | 4.6 (3.1,6.0) |
F | 4 | 0.3 (0.1,0.7) | 43 | 5.2 (3.6,6.7) | |
Breast | M | 0 | - | 1 | 0.1 (0.0,0.7) |
F | 0 | - | 42 | 4.9 (3.4,6.4) | |
Genital/other reproductive | M | 0 | - | 0 | - |
F | 1 | 0.1 (0.0,0.6) | 85 | 9.9 (7.8,12.0) | |
Lung and bronchial | M | 1 | 0.1 (0.0,0.4) | 7 | 0.8 (0.3,1.7) |
F | 2 | 0.1 (0.0,0.5) | 5 | 0.6 (0.2,1.4) | |
Colorectal | M | 0 | - | 19 | 2.3 (1.4,3.6) |
F | 2 | 0.1 (0.0,0.5) | 9 | 1.1 (0.5,2.0) | |
TOTAL
| M | 886 | 76.8 (71.7,81.9) | 957 | 115.7 (108.3,123.0) |
F | 791 | 73.0 (67.8,78.1) | 942 | 114.3 (107.0,121.6) |
1968–1980 | 1981–1993 | 1994–2005 | % Ann. Inc | M/F diff | |||||
---|---|---|---|---|---|---|---|---|---|
CNS tumours
| Male | 134 | 28.5 (23.6,33.4) | 115 | 29.9 (24.4,35.4) | 133 | 38.4 (31.8,45.0) | 1.5 (0.5,2.5) | 0.74 |
Female | 116 | 26.2 (21.3,31.0) | 91 | 25.1 (19.9,30.3) | 102 | 32.7 (26.3,39.2) | 1.2 (0.2,2.2) | ||
Ependymomas | Male | 18 | 4.3 (2.5,6.8) | 17 | 4.7 (2.7,7.5) | 16 | 4.9 (2.8,8.0) | 0.7 (-1.7,3.2) | 0.61 |
Female | 10 | 2.4 (1.2,4.5) | 6 | 1.6 (0.6,3.5) | 5 | 1.9 (0.6,4.5) | -0.5 (-4.6,3.6) | ||
Astrocytomas | Male | 38 | 7.9 (5.4,10.5) | 44 | 11.1 (7.8,14.4) | 55 | 15.5 (11.3,19.6) | 3.1 (1.7,4.6) | 0.33 |
Female | 36 | 8.1 (5.4,10.8) | 29 | 7.9 (5.3,11.4) | 61 | 19.5 (14.5,24.5) | 4.4 (2.3,6.6) | ||
PNET | Male | 35 | 7.5 (4.9,10.0) | 16 | 4.4 (2.5,7.2) | 27 | 8.1 (5.3,11.8) | 0.6 (-1.6,2.9) | 0.86 |
Female | 16 | 3.8 (2.1,6.1) | 15 | 4.3 (2.4,7.1) | 14 | 4.7 (2.5,7.8) | 0.9 (-1.7,3.6) | ||
Other gliomas | Male | 13 | 2.9 (1.5,5.0) | 10 | 2.6 (1.2,4.7) | 11 | 3.1 (1.5,5.6) | 0.7 (-2.4,3.9) | 0.42 |
Female | 15 | 3.4 (1.9,5.6) | 9 | 2.6 (1.2,4.9) | 10 | 2.9 (1.4,5.4) | -1.0 (-3.7,1.7) | ||
Sympathetic nervous system tumours
| Male | 32 | 7.4 (4.8,10.0) | 43 | 12.6 (8.9,16.4) | 27 | 9.6 (6.3,14.0) | 0.9 (-0.5,2.4) | 0.29 |
Female | 25 | 6.9 (4.5,10.2) | 34 | 10.3 (6.8,13.8) | 36 | 13.3 (8.9,17.6) | 2.2 (0.4,3.9) | ||
Retinoblastoma
| Male | 16 | 4.2 (2.4,6.8) | 12 | 3.6 (1.9,6.3) | 10 | 3.6 (1.7,6.6) | -0.3 (-3.6,3.1) | 0.42 |
Female | 26 | 7.2 (4.7,10.5) | 17 | 5.4 (3.1,8.6) | 7 | 2.7 (1.1,5.6) | -2.1 (-5.0,0.8) | ||
Renal tumours
| Male | 28 | 6.8 (4.5,9.9) | 18 | 5.1 (3.0,8.0) | 25 | 9.0 (5.8,13.3) | 0.5 (-1.5,2.6) | 0.86 |
Female | 31 | 8.3 (5.3,11.2) | 29 | 8.8 (5.9,12.7) | 25 | 9.4 (6.1,13.9) | 0.3 (-1.5,2.1) | ||
Hepatoblastomas
| Male | 1 | 0.3 (0.0,1.5) | 1 | 0.3 (0.0,1.7) | 5 | 1.9 (0.6,4.4) | 7.3 (-0.2,14.9) | 0.18 |
Female | 5 | 1.3 (0.4,3.0) | 2 | 0.6 (0.1,2.3) | 3 | 1.2 (0.2,3.4) | 0.5 (-5.5,6.6) | ||
Bone tumours
| Male | 30 | 5.3 (3.4,7.2) | 17 | 4.0 (2.3,6.4) | 18 | 4.6 (2.7,7.3) | 0.3 (-2.1,2.7) | 0.58 |
Female | 21 | 4.1 (2.5,6.3) | 21 | 5.1 (3.1,7.8) | 14 | 3.8 (2.1,6.4) | -0.7 (-3.3,1.9) | ||
Osteosarcoma | Male | 18 | 3.1 (1.9,5.0) | 8 | 1.9 (0.8,3.8) | 8 | 2.0 (0.9,3.9) | -0.9 (-4.3,2.6) | 0.80 |
Female | 16 | 3.1 (1.8,5.1) | 12 | 2.9 (1.5,5.0) | 9 | 2.5 (1.1,4.7) | -1.5 (-4.2,1.3) | ||
Ewing's sarcoma | Male | 12 | 2.2 (1.1,3.8) | 9 | 2.0 (0.9,3.9) | 8 | 2.0 (0.9,4.0) | 0.3 (-2.4,3.0) | 0.94 |
Female | 4 | 0.8 (0.2,2.2) | 9 | 2.2 (1.0,4.2) | 3 | 0.8 (0.2,2.4) | 0.1 (-4.9,5.1) | ||
Soft tissue sarcomas
| Male | 45 | 9.6 (6.7,12.4) | 46 | 12.5 (8.9,16.2) | 36 | 11.2 (7.5,14.9) | 1.3 (-0.2,2.8) | 0.70 |
Female | 28 | 6.0 (4.0,8.7) | 22 | 5.8 (3.6,8.8) | 22 | 7.0 (4.4,10.7) | 0.8 (-1.2,2.9) | ||
Rhabdomyosarcoma | Male | 24 | 5.4 (3.4,8.1) | 26 | 7.2 (4.7,10.6) | 25 | 8.3 (5.3,12.3) | 2.4 (0.2,4.5) | 0.09 |
Female | 19 | 4.3 (2.5,6.7) | 10 | 2.7 (1.3,5.1) | 10 | 3.7 (1.7,6.7) | -0.4 (-2.7,1.9) | ||
Other | Male | 21 | 4.2 (2.6,6.4) | 20 | 5.3 (3.2,8.2) | 11 | 2.9 (1.4,5.2) | -0.4 (-2.9,2.1) | 0.19 |
Female | 9 | 1.7 (0.8,3.3) | 12 | 3.1 (1.6,5.4) | 12 | 3.4 (1.7,5.9) | 2.5 (-1.1,6.0) | ||
Germ cell tumours
| Male | 17 | 4.4 (2.5,7.0) | 18 | 5.1 (3.0,8.1) | 20 | 6.5 (4.0,10.2) | 2.1 (-0.7,4.8) | 0.02 |
Female | 8 | 1.8 (0.7,3.5) | 20 | 5.7 (3.5,8.9) | 32 | 10.6 (6.9,14.4) | 6.2 (4.1,8.3) | ||
Gonadal | Male | 13 | 3.4 (1.8,5.8) | 13 | 3.9 (2.1,6.6) | 6 | 2.1 (0.8,4.6) | -1.1 (-4.9,2.7) | 0.001 |
Female | 2 | 0.4 (0.0,1.3) | 2 | 0.5 (0.1,1.8) | 14 | 4.0 (2.1,6.7) | 8.6 (4.3,12.9) | ||
Non-gonadal | Male | 4 | 1.0 (0.3,2.5) | 5 | 1.2 (0.4,2.9) | 14 | 4.4 (2.4,7.5) | 7.2 (2.6,11.8) | 0.50 |
Female | 6 | 1.4 (0.5,3.1) | 18 | 5.2 (3.1,8.3) | 18 | 6.6 (3.9,10.5) | 5.4 (2.8,7.9) | ||
Carcinomas
| Male | 11 | 2.0 (1.0,3.7) | 13 | 3.0 (1.6,5.1) | 15 | 4.2 (2.3,6.9) | 3.2 (0.1,6.3) | 0.31 |
Female | 17 | 3.8 (2.2,6.1) | 20 | 5.0 (3.0,7.7) | 17 | 5.0 (2.9,8.0) | 1.1 (-1.5,3.7) | ||
Thyroid | Male | 2 | 0.4 (0.0,1.3) | 2 | 0.5 (0.1,1.7) | 5 | 1.3 (0.4,3.0) | 5.9 (-0.4,12.2) | 0.07 |
Female | 4 | 0.9 (0.2,2.4) | 3 | 0.7 (0.1,2.0) | 2 | 0.6 (0.1,2.0) | -1.8 (-7.1,3.4) | ||
Melanoma | Male | 2 | 0.3 (0.0,1.2) | 3 | 0.7 (0.1,2.0) | 2 | 0.6 (0.1,2.3) | 4.3 (-2.8,11.4) | 0.81 |
Female | 3 | 0.7 (0.1,2.2) | 8 | 2.1 (0.9,4.1) | 5 | 1.6 (0.5,3.7) | 3.1 (-2.7,9.0) | ||
Skin | Male | 0 | - | 2 | 0.4 (0.1,1.5) | 2 | 0.5 (0.1,1.9) | 9.6 (0.0,19.2) | 0.46 |
Female | 0 | - | 2 | 0.5 (0.1,1.6) | 2 | 0.5 (0.1,1.8) | 4.5 (-4.8,13.8) | ||
Breast | Male | 0 | - | 0 | - | 0 | - | - | - |
Female | 0 | - | 0 | - | 0 | - | - | ||
Genital/other reproductive | Male | 0 | - | 0 | - | 0 | - | - | - |
Female | 0 | - | 1 | 0.3 (0.0,1.8) | 0 | - | 2.9 (-15.1,20.9) | ||
Lung and bronchial | Male | 1 | 0.2 (0.0,1.1) | 0 | - | 0 | - | -12.1 (-25.9,1.6) | 0.12 |
Female | 1 | 0.2 (0.0,1.0) | 0 | - | 1 | 0.3 (0.0,1.4) | 2.8 (-9.6,15.2) | ||
Colorectal | Male | 0 | - | 0 | - | 0 | - | - | - |
Female | 1 | 0.2 (0.0,1.0) | 0 | - | 1 | 0.3 (0.0,1.4) | 2.5 (-9.9,14.8) | ||
TOTAL
| Male | 314 | 68.6 (60.8,76.3) | 283 | 76.1 (67.1,85.0) | 289 | 89.0 (78.6,99.4) | 1.3 (0.7,1.9) | 0.84 |
Female | 277 | 65.4 (57.6,73.2) | 256 | 71.8 (62.9,80.7) | 258 | 85.7 (75.0,96.3) | 1.2 (0.5,2.0) |
1968–1980 | 1981–1993 | 1994–2005 | % Ann Inc | M/F diff | |||||
---|---|---|---|---|---|---|---|---|---|
CNS tumours
| Male | 87 | 29.0 (22.9,35.1) | 84 | 28.4 (22.3,34.5) | 53 | 23.6 (17.3,30.0) | -0.5 (-1.9,0.8) | 0.60 |
Female | 59 | 19.8 (14.7,24.8) | 59 | 20.2 (15.1,25.4) | 47 | 20.8 (14.9,26.8) | 0.0 (-1.5,1.5) | ||
Ependymomas | Male | 8 | 2.7 (1.2,5.3) | 10 | 3.4 (1.6,6.3) | 3 | 1.3 (0.3,3.9) | -2.1 (-5.5,1.4) | 0.19 |
Female | 2 | 0.7 (0.1,2.5) | 1 | 0.4 (0.0,2.1) | 3 | 1.3 (0.3,3.9) | 3.2 (-3.9,10.3) | ||
Astrocytomas | Male | 28 | 9.4 (6.2,13.6) | 25 | 8.6 (5.6,12.7) | 23 | 10.2 (6.5,15.3) | 0.4 (-1.9,2.7) | 0.71 |
Female | 21 | 7.0 (4.4,10.8) | 17 | 5.8 (3.4,9.3) | 16 | 7.1 (4.0,11.5) | -0.2 (-2.4,2.0) | ||
PNET | Male | 8 | 2.6 (1.1,5.2) | 3 | 1.0 (0.2,2.9) | 2 | 0.9 (0.1,3.2) | -2.8 (-7.9,2.2) | 0.99 |
Female | 4 | 1.4 (0.4,3.5) | 2 | 0.7 (0.1,2.5) | 1 | 0.5 (0.0,2.6) | -2.9 (-8.8,3.1) | ||
Other gliomas | Male | 14 | 4.6 (2.5,7.8) | 17 | 5.6 (3.3,9.0) | 5 | 2.2 (0.7,5.2) | -1.4 (-4.4,1.5) | 0.99 |
Female | 11 | 3.6 (1.8,6.5) | 10 | 3.6 (1.7,6.7) | 5 | 2.2 (0.7,5.1) | -1.4 (-5.3,2.4) | ||
Sympathetic nervous system tumours
| Male | 1 | 0.3 (0.0,1.8) | 6 | 2.1 (0.8,4.6) | 2 | 0.9 (0.1,3.2) | 1.5 (-4.1,7.0) | 0.71 |
Female | 2 | 0.7 (0.1,2.4) | 3 | 1.1 (0.2,3.1) | 4 | 1.9 (0.5,4.8) | 3.1 (-3.4,9.7) | ||
Retinoblastoma
| Male | 0 | - | 0 | - | 0 | - | - | - |
Female | 0 | - | 0 | - | 0 | - | - | ||
Renal tumours
| Male | 1 | 0.3 (0.0,1.8) | 3 | 1.0 (0.2,2.9) | 4 | 1.7 (0.5,4.3) | 2.8 (-4.0,9.6) | 0.32 |
Female | 3 | 1.0 (0.2,3.0) | 3 | 0.9 (0.2,2.7) | 1 | 0.4 (0.0,2.4) | -1.8 (-7.9,4.3) | ||
Hepatoblastomas
| Male | 0 | - | 0 | - | 0 | - | - | - |
Female | 1 | 0.3 (0.0,1.8) | 1 | 0.3 (0.0,1.7) | 0 | - | -4.4 (-16.0,7.3) | ||
Bone tumours
| Male | 36 | 12.1 (8.2,16.1) | 50 | 17.7 (12.8,22.6) | 28 | 12.6 (8.4,18.3) | 0.2 (-1.7,2.0) | 0.15 |
Female | 19 | 6.4 (3.9,10.0) | 22 | 7.9 (4.9,11.9) | 25 | 11.6 (7.5,17.1) | 2.2 (0.2,4.2) | ||
Osteosarcoma | Male | 20 | 6.8 (4.2,10.6) | 23 | 8.2 (5.2,12.3) | 17 | 7.7 (4.5,12.3) | 0.1 (-2.6,2.8) | 0.10 |
Female | 10 | 3.4 (1.6,6.2) | 12 | 4.3 (2.2,7.5) | 17 | 7.9 (4.6,12.7) | 3.5 (0.5,6.5) | ||
Ewing's sarcoma | Male | 9 | 3.0 (1.4,5.7) | 20 | 7.0 (4.3,10.8) | 7 | 3.2 (1.3,6.6) | 1.0 (-1.9,4.0) | 0.50 |
Female | 6 | 2.1 (0.8,4.5) | 5 | 1.7 (0.6,4.1) | 5 | 2.3 (0.8,5.4) | -0.7 (-4.8,3.4) | ||
Soft tissue sarcomas
| Male | 27 | 9.1 (6.0,13.3) | 29 | 9.9 (6.6,14.2) | 33 | 14.6 (9.6,19.6) | 1.9 (-0.4,4.2) | 0.55 |
Female | 27 | 9.2 (6.1,13.4) | 39 | 13.3 (9.1,17.5) | 28 | 12.7 (8.4,18.4) | 1.0 (-0.8,2.9) | ||
Rhabdomyosarcoma | Male | 5 | 1.7 (0.6,4.0) | 2 | 0.7 (0.1,2.6) | 7 | 3.2 (1.3,6.6) | 3.0 (-1.5,7.5) | 0.74 |
Female | 4 | 1.4 (0.4,3.6) | 13 | 4.6 (2.5,7.9) | 4 | 1.8 (0.5,4.5) | 2.0 (-2.2,6.1) | ||
Other | Male | 22 | 7.4 (4.6,11.2) | 27 | 9.1 (6.0,13.3) | 26 | 11.4 (7.5,16.7) | 1.7 (-1.0,4.4) | 0.60 |
Female | 23 | 7.8 (4.9,11.7) | 26 | 8.7 (5.7,12.7) | 24 | 10.9 (7.0,16.3) | 0.7 (-1.7,3.2) | ||
Germ cell tumours
| Male | 70 | 23.1 (17.7,28.6) | 115 | 37.5 (30.6,44.4) | 107 | 46.5 (37.7,55.3) | 2.1 (0.6,3.7) | 0.74 |
Female | 44 | 14.6 (10.3,18.9) | 35 | 11.6 (7.8,15.5) | 48 | 21.6 (15.5,27.7) | 1.7 (-0.2,3.6) | ||
Gonadal | Male | 65 | 21.5 (16.2,26.7) | 101 | 32.8 (26.4,39.3) | 94 | 40.9 (32.6,49.1) | 1.9 (0.3,3.4) | 0.51 |
Female | 29 | 9.6 (6.4,13.8) | 26 | 8.6 (5.6,12.7) | 31 | 13.8 (9.0,18.7) | 1.0 (-1.0,3.0) | ||
Non-gonadal | Male | 5 | 1.7 (0.5,3.9) | 14 | 4.6 (2.5,7.8) | 13 | 5.6 (3.0,9.6) | 4.4 (1.1,7.7) | 0.65 |
Female | 15 | 5.0 (2.8,8.2) | 9 | 3.0 (1.4,5.7) | 17 | 7.8 (4.5,12.4) | 3.2 (-0.7,7.1) | ||
Carcinomas
| Male | 78 | 25.7 (20.0,31.4) | 75 | 24.6 (19.0,30.2) | 68 | 29.7 (22.6,36.8) | 0.2 (-1.4,1.8) | 0.07 |
Female | 131 | 43.1 (35.7,50.5) | 164 | 53.9 (45.6,62.1) | 177 | 78.2 (66.7,89.7) | 2.2 (0.7,3.7) | ||
Thyroid | Male | 6 | 2.0 (0.7,4.3) | 8 | 2.8 (1.2,5.5) | 9 | 3.9 (1.8,7.4) | 2.5 (-2.2,7.2) | 0.90 |
Female | 13 | 4.4 (2.3,7.5) | 22 | 7.4 (4.6,11.3) | 26 | 11.5 (7.5,16.9) | 2.8 (0.1,5.6) | ||
Melanoma | Male | 20 | 6.7 (4.1,10.4) | 22 | 7.2 (4.5,10.9) | 19 | 8.3 (5.0,13.0) | 0.6 (-2.1,3.3) | 0.03 |
Female | 25 | 8.3 (5.3,12.2) | 54 | 17.8 (13.0,22.5) | 69 | 30.8 (23.5,38.1) | 4.6 (2.2,7.1) | ||
Skin | Male | 9 | 2.9 (1.3,5.5) | 9 | 2.9 (1.3,5.5) | 21 | 9.1 (5.6,13.8) | 4.7 (0.5,8.9) | 0.61 |
Female | 11 | 3.6 (1.8,6.5) | 12 | 4.1 (2.1,7.1) | 20 | 8.8 (5.4,13.6) | 3.2 (-0.4,6.9) | ||
Breast | Male | 0 | - | 0 | - | 1 | 0.5 (0.0,2.6) | 11.8 (-8.4,32.0) | 0.25 |
Female | 14 | 4.5 (2.5,7.6) | 18 | 5.7 (3.4,9.0) | 10 | 4.3 (2.1,8.0) | -0.3 (-2.9,2.3) | ||
Genital/other reproductive | Male | 0 | - | 0 | - | 0 | - | - | - |
Female | 31 | 10.0 (6.5,13.5) | 28 | 8.8 (5.9,12.8) | 26 | 11.3 (7.4,16.6) | 0.5 (-1.7,2.8) | ||
Lung and bronchial | Male | 4 | 1.3 (0.4,3.4) | 3 | 1.0 (0.2,2.9) | 0 | - | -6.2 (-12.5,0.2) | 0.23 |
Female | 2 | 0.7 (0.1,2.4) | 1 | 0.3 (0.0,1.7) | 2 | 0.9 (0.1,3.3) | 0.0 (-7.7,7.8) | ||
Colorectal | Male | 10 | 3.3 (1.6,6.1) | 5 | 1.7 (0.6,4.0) | 4 | 1.7 (0.5,4.4) | -3.5 (-7.4,0.4) | 0.01 |
Female | 1 | 0.3 (0.0,1.8) | 3 | 1.0 (0.2,2.9) | 5 | 2.2 (0.7,5.0) | 8.2 (0.1,16.3) | ||
TOTAL
| Male | 300 | 99.8 (88.5,111.1) | 362 | 121.1 (108.6,133.6) | 295 | 129.7 (114.9,144.5) | 0.8 (-0.2,1.8) | 0.30 |
Female | 286 | 95.2 (84.1,106.2) | 326 | 109.2 (97.3,121.1) | 330 | 147.2 (131.3,163.1) | 1.6 (0.5,2.7) |